Physician profile
Patrick B Wu
NPI 1669932794
$10,632.56
in general payments reported to CMS, 2019-2025
13 companies · $2,771 in 2025
The $2,771 reported for 2025 was more than what 86% of Glaucoma Specialist providers received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $4,223 · 2024: $3,639 · 2025: $2,771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,316 · Travel and Lodging: $4,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,315.84 |
| Travel and Lodging | $4,316.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $2,668.67 | 2023-2024 | Trulign Iol, Stellaris Elite, Envista Mx60 Iol |
| Glaukos Corporation | $2,588.89 | 2023-2025 | Istent Trabecular Micro-Bypass System Model Is3, Idosetr, Idose |
| Abbvie INC. | $2,354.83 | 2023-2025 | Durysta, Xen Glaucoma Treatment System |
| Sight Sciences, INC. | $1,582.80 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| New World Medical,INC. | $708.47 | 2023-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Tarsus Pharmaceuticals, INC. | $187.28 | 2025 | Xdemvy |
| Carl Zeiss Meditec USA, INC. | $129.35 | 2024 | Veracity Surgical |
| Biotissue Holdings INC. | $115.53 | 2023 | |
| Kedrion Biopharma, INC. | $115.43 | 2025 | Ryplazim |
| Vertex Pharmaceuticals Incorporated | $109.39 | 2025 | |
| Harrow Eye, LLC | $45.33 | 2024 | Vevye |
| Mallinckrodt Hospital Products INC. | $13.41 | 2023 | Acthar |
| Sun Pharmaceutical Industries INC. | $13.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.